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ABSTRACT: 
— We herein describe two severe cases of Mediterranean spotted fever caused by Rickettsia conorii. The ar-
ticle presents polymerase chain reaction-restriction analysis as an early diagnostic tool for rickettsiosis
caused by spotted fever group Rickettsiae. Timely microbiological diagnosis, the combined use of antibi-
otics, intensive care measures and a multidisciplinary team approach are fundamental to manage these
serious diseases.
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INTRODUCTION
Mediterranean spotted fever (MSF) is caused by Rick-
ettsia conorii and transmitted by the brown dog tick
Rhipicephalus sanguineus1-2. In Italy, more than 400
cases are reported every year and nearly half of them
occur in Sicily. The disease usually has a benign course
and is characterized by fever, myalgia and a papular rash
with an inoculation eschar, called “tache noir”, at the site
of the tick bite. Nevertheless, severe forms have been
sporadically reported. We report two cases of MSF, who
developed septic shock and multiple organ failure
(MOF), in which the diagnostic laboratory had a major
role in their clinical management.
CASE REPORTS
We describe our experience with 2 patients (54-and 64-
year-old males) who presented with fever and general
maculopapular rash with rare petechial elements on the
palms of the hands. Patient 1 also presented petechial el-
ements on the soles of the feet. In both cases, laboratory
tests revealed multi-organ involvement with acute renal
failure, increased transaminases, lactate dehydrogenase
and D-dimer, associated with high inflammatory mark-
ers. MSF was suspected and parenteral therapy with chlo-
ramphenicol 500 mg q6h and ciprofloxacin 500 mg q12h
was initiated in both patients. Due to sepsis-induced
MOF, both patients were transferred to the Intensive Care
Unit (ICU), where they were intubated and resuscitated.
After a week, the clinical condition of patient 1 improved
with the stabilization of all vital parameters, and he was
transferred to our Department. Patient 2’s clinical condi-
tion worsened, and intubation and mechanical ventilation
were required; however, he did not improve and he died
because of respiratory failure ten days later.
In the fatal case, polymerase chain reaction (PCR)
molecular investigation performed 6 hours (h) before
death was negative as the serological assays, and the di-
agnosis was confirmed by autopsy, whereas in the case
with a favorable evolution, PCR confirmed the diagnosis
of MSF within 6 h of hospital admission and serological
investigations were positive just two weeks after hospi-
talization. Table 1 shows the different clinical and thera-
peutic management in the two case reports. 
METHODS
Members of the Rickettsia spotted fever and typhus
groups were identified using a previously published
highly sensitive and specific real-time TaqMan PCR assay
specific for a 74-bp fragment of the gltA gene3. Rickettsial
DNA was extracted from both whole blood and buffy coat
samples with a DNA extraction kit (Qiagen, Hilden, Ger-
many) as per manufacturer’s specifications. Specific anti-
rickettsial immunoglobulin M (IgM) and IgG
determinations were performed by an enzyme-linked im-
munosorbent assay (ELISA) or an indirect immunofluo-
rescence (IIF) assay. Antigens were freshly prepared in
the hospital laboratory as described previously4.
CONCLUSIONS
Mediterranean spotted fever (MSF) is a tick-borne dis-
ease caused by Rickettsia conorii. MSF is transmitted by
the dog tick Rhipicephalus sanguineus5. The incubation
period is around 7-8 days after the tick bite. 
Spotted fever group rickettsiosis can be diagnosed by
serological tests or molecular methods6. The detection of
antibodies can rely on indirect immune fluorescence or
immune enzyme assays. However, serological investiga-
tion is not useful to confirm the disease in its early stages,
when diagnosis can be usually made considering clinical
and epidemiological aspects.
Methods such as one-step, real time RT-PCR or nested
RT-PCR are now widely used to detect Rickettsiae of spotted
fever group in acute-phase serum samples. In the fatal case,
delayed medical consultation and late initiation of antimicro-
bial therapy (4 days after the onset of symptoms), as well as
older age, probably contributed to the unfavorable course.
Early and aggressive multidisciplinary management
could influence the evolution of MSF severe complica-
tions, such as MOF. Our clinical cases confirm the limi-
tations of serological assays in the acute phase of MSF,
whereas early PCR assays to diagnose rickettsiosis may
favorably affect therapeutic management. It is important
to investigate if SOFA and DIC scores can influence
DNA results. Finally, the role of chloramphenicol and
combined antibiotic treatment in the acute phase of se-
vere disease should be reconsidered.
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Table 1. Characteristics of the two patients with Mediterranean spotted fever admitted to our Unit
Variables after hospital admission (d=days; h=hours)                                  Fatal case                             Favorable case
Signs and symptoms
Fever                                                                                                                         3 d                                              2 d
Rash                                                                                                                         24 h                                           18 h
Eschar                                                                                                                       yes                                              no
Diagnostic assays                                                                                                                                                         
Rickettsial DNA                                                                                             Negative (28 h)                           Positive (4 h)
Anti-rickettsial immunoglobulin M and IgG                                                  Negative (2 d)                           Positive (14 d)
Autopsy                                                                                                                    yes                                              no
Delayed specific treatment after symptom onset (d)                                             4                                                 2
Antimicrobial treatment after hospital admission
Chloramphenicol e.v.                                                                                               12 h                                            4 h 
Ciprofloxacin e.v.                                                                                                     10 h                                            4 h
Oral tetracycline                                                                                                       4 h                                            None
ICU parameters                                                                                                                                                           
Transferred to the ICU                                                                                            24 h                                            6 h
Glasgow Coma Scale value on ICU admission                                                          7                                                9 
SOFA score on ICU admission                                                                                   9                                                10
DIC score                                                                                                                 5.5                                              7.5
Orotracheal intubation                                                                                     On admission                                After 8 h
